Silverback Therapeutics Inc

NASDAQ:SBTX 3:59:51 PM EDT

9.51

+0.13 (+1.39%)

Silverback Therapeutics Inc Stock, NASDAQ:SBTX

500 Fairview Avenue North, Suite 600, Seattle, Washington 98109

United States of America

Phone: +1.206.456.2900

Number of Employees: 54

http://www.silverbacktx.com

Description

Silverback Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. It focuses on proprietary ImmunoTAC technology platform to develop systemically delivered, tissue targeted therapeutics for the treatment of cancer, chronic viral infections, and other serious diseases. The company was founded by Peter A. Thompson in 2016 and is headquartered in Seattle, WA.